A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)
Condition(s):Malignant Melanoma; Squamous Cell Carcinoma of SkinLast Updated:February 21, 2024Active, not recruiting